Association of the insulin-like growth factor binding protein 3 (IGFBP-3) polymorphism with longevity in Chinese nonagenarians and centenarians

Aging

Volumn 6, Issue 11, 2014, Pages 944-956

  He, Yong Han ^a,b   Lu, Xiang ^a,b   Yang, Li Qin ^a,b   Xu, Liang You ^c   Kong, Qing Peng ^a,b  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases   (China)

^c Dujiangyan Longevity Research Centre   (China)

Author keywords

Insulin like growth factor binding protein 3; Longevity; Single nucleotide polymorphism

Indexed keywords

ATM PROTEIN; ATM PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN 3;

AGE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; EPIDEMIOLOGY; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; LONGEVITY; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

AGE FACTORS; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CASE-CONTROL STUDIES; CHINA; FORKHEAD TRANSCRIPTION FACTORS; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LONGEVITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920273003     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100703     Document Type: Article

References (32)

1. Murabito JM, Yuan R and Lunetta KL. The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. The journals of gerontology Series A, Biological sciences and medical sciences. 2012; 67:470-479.
2. Sebastiani P and Perls TT. The genetics of extreme longevity: lessons from the new England centenarian study. Frontiers in genetics. 2012; 3:277.
3. Guarente L and Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 2000; 408:255-262.
4. Kenyon C, Chang J, Gensch E, Rudner A and Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993; 366:461-464.
5. Partridge L and Gems D. Mechanisms of ageing: public or private? Nature reviews Genetics. 2002; 3(3):165-175.
6. Brooks-Wilson AR. Genetics of healthy aging and longevity. Human genetics. 2013; 132:1323-1338.
7. Bostock CV, Soiza RL and Whalley LJ. Genetic determinants of ageing processes and diseases in later life. Maturitas. 2009;62:225-229.
8. Novelli V, Viviani Anselmi C, Roncarati R, Guffanti G, Malovini A, Piluso G and Puca AA. Lack of replication of genetic associations with human longevity. Biogerontology. 2008; 9:85-92.
9. Barbieri M, Bonafe M, Franceschi C and Paolisso G. Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. American journal of physiology Endocrinology and metabolism. 2003; 285:E1064-1071.
10. Bartke A. Minireview: role of the growth hormone/insulinlike growth factor system in mammalian aging. Endocrinology. 2005; 146:3718-3723.
11. Tatar M, Bartke A and Antebi A. The endocrine regulation of aging by insulin-like signals. Science. 2003; 299:1346-1351.
12. Blagosklonny MV. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell death & disease. 2013; 4:e964.
13. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV and Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell cycle. 2009; 8:1888-1895.
14. Leontieva OV, Demidenko ZN and Blagosklonny MV. Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium. Cell death & disease. 2014; 5:e1214.
15. Salminen A and Kaarniranta K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cellular signalling. 2010; 22:573-577.
16. Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, Donia M, Fagone P, Malaponte G, et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging. 2011; 3:192-222.
17. Anselmi CV, Malovini A, Roncarati R, Novelli V, Villa F, Condorelli G, Bellazzi R and Puca AA. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation research. 2009; 12:95-104.
18. Flachsbart F, Caliebe A, Kleindorp R, Blanche H, von Eller-Eberstein H, Nikolaus S, Schreiber S and Nebel A. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106:2700-2705.
19. Li Y, Wang WJ, Cao H, Lu J, Wu C, Hu FY, Guo J, Zhao L, Yang F, Zhang YX, Li W, Zheng GY, Cui H, et al. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Human molecular genetics. 2009; 18:4897-4904.
20. Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC, Rodriguez B and Curb JD. FOXO3A genotype is strongly associated with human longevity. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105:13987-13992.
21. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nature reviews Cancer. 2003; 3:155-168.
22. McKinnon PJ. ATM and ataxia telangiectasia. EMBO reports. 2004; 5:772-776.
23. Chen T, Dong B, Lu Z, Tian B, Zhang J, Zhou J, Wu H, Zhang Y, Wu J, Lin P, Zhang J, Xu H and Mo X. A functional single nucleotide polymorphism in promoter of ATM is associated with longevity. Mechanisms of ageing and development. 2010; 131:636-640.
24. Piaceri I, Bagnoli S, Tedde A, Sorbi S and Nacmias B. Ataxiatelangiectasia mutated (ATM) genetic variant in Italian centenarians. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013; 34:573-575.
25. Kaplan RC, Petersen AK, Chen MH, Teumer A, Glazer NL, Doring A, Lam CS, Friedrich N, Newman A, Muller M, Yang Q, Homuth G, Cappola A, et al. A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Human molecular genetics. 2011; 20:1241-1251.
26. Rajaram S, Baylink DJ and Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine reviews. 1997; 18:801-831.
27. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N. Induction of the growth inhibitor IGFbinding protein 3 by p53. Nature. 1995; 377:646-649.
28. Feng Z. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harbor perspectives in biology. 2010; 2:a001057.
29. Feng Z and Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends in cell biology. 2010; 20:427-434.
30. Gong YY, Xie L, Zhou WP, Zhang YP, Gong YY, Xie L, Lian SG, Yang J, Wang XY, Yang Z, Gao SJ, Xu LY and Zhou WP. Glucose and lipid profile of a long-lived rural Han Chinese population and their families in southwest China. Journal of the American Geriatrics Society. 2009; 57:567-568.
31. Sambrook J, Fritsch EF and Maniatis T. 1989. Molecular cloning: Cold spring harbor laboratory press New York.
32. Valdes AM, Van Oene M, Hart DJ, Surdulescu GL, Loughlin J, Doherty M and Spector TD. Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis and rheumatism. 2006; 54:533-539.